ID
12662
Description
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger
Keywords
Versions (2)
- 12/8/15 12/8/15 -
- 7/23/16 7/23/16 -
Uploaded on
December 8, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Adverse Event Psoriasis MIPSO EudraCT 2014-003022-40
Adverse Event Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM
Description
Adverse Event Questionaire
Description
AE: Number
Data type
integer
Description
AE: Term
Data type
text
Description
AE: Start date
Data type
date
Description
AE: Start time, if relevant
Data type
time
Description
AE: Serious event
Data type
boolean
Description
AE: Severity
Data type
integer
Description
AE: Related to study medication
Data type
integer
Description
AE: Action taken with study treatment
Data type
integer
Description
AE that caused study discontinuation
Data type
boolean
Description
AE: End date
Data type
date
Description
AE: End time, if relevant
Data type
time
Description
AE: Ongoing
Data type
boolean
Description
AE: Outcome
Data type
integer
Similar models
Adverse Event Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM